Alm A, Schoenfelder J, McDermott J: A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma. Arch Ophthalmol 122: 957-965, 2004
Chiba T, Kashiwagi K, Kogure S et al: Iridial pigmentation induced by latanoprost ophthalmic solution in Japanese glaucoma patients. J Glaucoma 10: 406-410, 2001
Dutkiewicz R, Albert DM, Levin LA: Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines. Exp Eye Res 70: 563-569, 2000